Search - tctmd.com

Displaying 121 - 140 of 464

Sort: Relevancy | Date

News Daily News

New Heart Failure After AF Diagnosis Merits More Attention

Todd Neale

April 18, 2024

News Conference News ACC 2024

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Caitlin E. Cox

April 15, 2024

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Shelley Wood

April 06, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Daily News

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

Todd Neale

March 25, 2024

News Daily News

Internists in HF: A Solution to a Lack of Care?

Yael L. Maxwell

March 19, 2024

News Daily News

US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users

Caitlin E. Cox

March 18, 2024

News Daily News

Cognitive Impairment a Real Concern in HF Patients: HFSA

Caitlin E. Cox

March 13, 2024

News Daily News

Physicians (Mostly) Negative on Private Equity in Healthcare

Michael O'Riordan

March 13, 2024

News Conference News THT 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Michael O'Riordan

March 11, 2024

News Daily News

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Todd Neale

March 11, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

Cardiac Contractility Modulator as an Option for Advanced Heart Failure Patients Dependent on Low Dose inotropes

Presenter: Kanika P. Mody

March 06, 2024

Presentation THT 2024

Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve post-LVAD Reverse Cardiac Remodeling

Presenter: Stavros G. Drakos

March 05, 2024

Presentation THT Abstracts 2024

Use of EMR-Based Clinical Workflows Improves Access and Equity for Patients with Advanced Heart Failure 2013 A Single Center Experience

March 05, 2024

Presentation THT 2024

How to Manage VT in Advanced HF and Post-LVAD Patients

Presenter: Jakub Sroubek

March 05, 2024

Presentation THT 2024

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Presenter: Lothar Roessig

March 05, 2024

Presentation THT 2024

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Presenter: Daniel Asemota

March 05, 2024

Presentation THT Abstracts 2024

Aortic Pulsatility Index does not predict use of temporary mechanical support among patients with Advanced Heart Failure Awaiting Cardiac Transplant.

Presenter: Muhammad Saad

March 04, 2024

Advertisement

New Heart Failure After AF Diagnosis Merits More Attention

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

April 2024 Dispatch for the CV Team

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

Internists in HF: A Solution to a Lack of Care?

US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users

Cognitive Impairment a Real Concern in HF Patients: HFSA

Physicians (Mostly) Negative on Private Equity in Healthcare

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Cardiac Contractility Modulator as an Option for Advanced Heart Failure Patients Dependent on Low Dose inotropes

Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve post-LVAD Reverse Cardiac Remodeling

Use of EMR-Based Clinical Workflows Improves Access and Equity for Patients with Advanced Heart Failure 2013 A Single Center Experience

How to Manage VT in Advanced HF and Post-LVAD Patients

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Aortic Pulsatility Index does not predict use of temporary mechanical support among patients with Advanced Heart Failure Awaiting Cardiac Transplant.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content